Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody production. These patients suffer from recurr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Kobrynski L
Format: article
Langue:EN
Publié: Dove Medical Press 2012
Sujets:
Accès en ligne:https://doaj.org/article/5352b791509b4c489e7611f4de1324f9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!